TrianglePUBLICATIONS · 22508825
Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2012 Jul 10
- First author
- Holowiecki J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Holowiecki J
- type
- Author
- name
- Grosicki S
- type
- Author
- name
- Giebel S
- type
- Author
- name
- Robak T
- type
- Author
- name
- Kyrcz-Krzemien S
- type
- Author
- name
- Kuliczkowski K
- type
- Author
- name
- Skotnicki AB
- type
- Author
- name
- Hellmann A
- type
- Author
- name
- Sulek K
- type
- Author
- name
- Dmoszynska A
- type
- Author
- name
- Kloczko J
- type
- Author
- name
- Jedrzejczak WW
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Holowiecki J
- type
- Author
- name
- Grosicki S
- type
- Author
- name
- Giebel S
- type
- Author
- name
- Robak T
- type
- Author
- name
- Kyrcz-Krzemien S
- type
- Author
- name
- Kuliczkowski K
- type
- Author
- name
- Skotnicki AB
- type
- Author
- name
- Hellmann A
- type
- Author
- name
- Sulek K
- type
- Author
- name
- Dmoszynska A
- type
- Author
- name
- Kloczko J
- type
- Author
- name
- Jedrzejczak WW
- type
- Author
- bibliography ids
- nci-bib-8c5e0401645662032ad58efa
- book metadata
- content sha256
- a00c90f80130ad78505995fa22d1cdcaac79abada7846e161111121fdf7bb630
- document type
- citation
- dois
- 10.1200/JCO.2011.37.1286
- electronic publication date
- display
- 2012 Apr 16
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22508825
- immutable id
- pubmed:22508825@a00c90f80130ad78505995fa22d1cdcaac79abada7846e161111121fdf7bb630
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 20
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2441-8
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22508825
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- bd7d661b16667426cee8f8d3185bee06931b8c292502d84d570b71d673fa4385
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 Jul 10
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.
Preserved source evidence · Not medical advice